Back to shop

Parteck® MXP (Polyvinyl alcohol) EMPROVE ESSENTIAL Ph Eur,JPE,USP

0.00

Clear
-
+

Total:

Description

Poor solubility of APIs is a critical challenge in drug development. One formulation technique to address this challenge is hot melt extrusion (HME). Our new Parteck® MXP is a polyvinyl alcohol-based excipient designed for hot melt extrusion to increase solubility and allow for stable and high drug loads for a broad range of APIs. The polymer  has a long safety record related to its usage in drugs and is generally recognized as safe (GRAS) by the U.S. Food and Drug Administration. Parteck® MXP complies with USP,  Ph. Eur., and JPE monographs.

Benefits of Parteck® MXP:

  • Enhanced solubility of APIs
  • Stable, high drug load under various conditions
  • High thermo-stability (above 200 °C) and a Broad API Application Range
  • Variety of final oral dosage forms with immediate or sustained release kinetics using the same extrudates
  • Ease of use thanks to optimized physical properties

Additional information

Manufacturer

Merck KGaA

Quality

EP, JPE, USP

Cas-No

9002-89-5

Einecs

618-340-9

Composition

Polyvinyl alcohol

Dosage Form

Capsules, extrudates, film, Granules, HME, hot-melt extruded tablets, implants, Tablets, transdermal patches

Function

Matrix polymer for solubility enhancement approaches via hot-melt extrusion

Documents and Links

Safety Data Sheet for Parteck® MXP (Polyvinyl alcohol) 141464

Download